First-in-human dose escalation of ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor, in advanced malignancies.

Justin C. Moser, Mark Voskoboynik, Nehal J. Lakhani, Michael Millward, Diwakar Davar, Wael A. Harb, Jing Yang, Gary Means, Kristi Manjarrez, Almudena Tercero, Hany Zayed, Jan Hillson, Christine Dela Cruz, Graciela Noemi Perez, Stanford L. Peng

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages3
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2021
EventVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -
Duration: 4 Jun 20218 Jun 2021

Cite this